In our MOC2 murine HNSCC cancer model, dual PI3Kγ/PD-L1 inhibition resulted in a reduced tumor burden and significantly improved survival compared with monotherapy, underscoring the therapeutic advantage of dual blockade. Here, CD274 is linked to cancer.